Cardioprotective effects of ischemic postconditioning in patients treated with primary percutaneous coronary intervention, evaluated by magnetic resonance.
Jacob Lønborg, Henning Kelbaek, Niels Vejlstrup...
https://pubmed.ncbi.nlm.nih.gov/20118154/Actively Recruiting
Led by Odense University Hospital · Updated on 2026-09-02
100
Participants Needed
1
Research Sites
252 weeks
Total Duration
This trial focuses on patients with ST-Elevation Myocardial Infarction STEMI undergoing primary percutaneous coronary intervention PCI. It aims to assess how modifying the coronary thrombus might reduce microvascular damage and limit heart muscle injury, measured by the myocardial salvage index after three months. The study also investigates coronary microvascular damage using invasive thermodilution methods before and after stent placement, and explores how pre-stenting physiological measurements relate to cardiac magnetic resonance imaging results. Participants will be randomly assigned to one of two groups coronary thrombus modification or standard stent implantation. The modification involves inflating a balloon briefly and repeatedly to alter the thrombus before stenting, while the control group receives standard stenting as usual. Physiological assessments using continuous and bolus thermodilution will be done before and after the intervention. Cardiac magnetic resonance imaging will be performed before hospital discharge and again three months later to evaluate heart muscle damage and function. During the study, participants will have detailed heart function tests, including invasive pressure and flow measurements and imaging scans to assess heart muscle salvage and damage. Follow-up will collect clinical outcomes such as death, heart attacks, repeat procedures, and hospitalizations for heart failure at 12 months, 24 months, and five years. The main outcome is the myocardial salvage index at three months, with additional measures from imaging and physiology evaluated at several time points. Participants are involved for at least three months with longer-term monitoring via medical records.
CONDITIONS
CORonary Thrombus Modification to Prevent MIcrovascular Damage in Patients With ST-segment Elevation Myocardial Infarction (The CORMI Trial)
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Odense University Hospital
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Single procedure visit
Participants receive either coronary thrombus modification followed by stent implantation or standard stent implantation as part of primary PCI.
1 visit (in-person)
Duration - At least 5 years
Participants undergo cardiac magnetic resonance imaging before hospital discharge and again at 3 months. Clinical outcomes are monitored via medical records up to 5 years after treatment.
Multiple follow-up visits and record reviews
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Jacob Lønborg, Henning Kelbaek, Niels Vejlstrup...
https://pubmed.ncbi.nlm.nih.gov/20118154/Odense University Hospital
Lead Sponsor